Search research articles
Contact Us
Filters
Showing results (111-120 of 125) with videos related to
Page
of 13
Sort By:
Blood Advances
|
April 12, 2021
The landscape of copy number variations in classical Hodgkin lymphoma: a joint KU Leuven and LYSA study on cell-free DNA
Lieselot Buedts, Iwona Wlodarska, Julio Finalet-Ferreiro, et al.
British Journal of Haematology
|
December 14, 2020
Convalescent plasma treatment of persistent severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with lymphoma with impaired humoral immunity and lack of neutralising antibodies
Albrecht Betrains, Laurent Godinas, F J Sherida H Woei-A-Jin, et al.
Acta Neurologica Belgica
|
March 15, 2018
A Belgian consensus protocol for autologous hematopoietic stem cell transplantation in multiple sclerosis
Guy Laureys, Barbara Willekens, Ludo Vanopdenbosch, et al.
The Lancet. Oncology
|
February 3, 2024
Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial
Kris Michael Mahadeo, Robert Baiocchi, Amer Beitinjaneh, et al.
Thrombosis and Haemostasis
|
September 21, 2018
Anti-ADAMTS13 Autoantibodies against Cryptic Epitopes in Immune-Mediated Thrombotic Thrombocytopenic Purpura
Elien Roose, Gestur Vidarsson, Kadri Kangro, et al.
Journal of Crohn'S & Colitis
|
May 23, 2018
Autologous Haematopoietic Stem Cell Transplantation for Crohn's Disease: A Retrospective Survey of Long-term Outcomes From the European Society for Blood and Marrow Transplantation
Charlotte K Brierley, Cristina Castilla-Llorente, Myriam Labopin, et al.
The Lancet. Haematology
|
October 1, 2019
Obstetric and maternal outcomes in patients diagnosed with Hodgkin lymphoma during pregnancy: a multicentre, retrospective, cohort study
Charlotte Maggen, Daan Dierickx, Pieternella Lugtenburg, et al.
Eclinicalmedicine
|
May 26, 2021
Comprehensive genome-wide analysis of routine non-invasive test data allows cancer prediction: A single-center retrospective analysis of over 85,000 pregnancies
Liesbeth Lenaerts, Nathalie Brison, Charlotte Maggen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 20, 2016
Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial
Ralf U Trappe, Daan Dierickx, Heiner Zimmermann, et al.
Transplantation
|
May 15, 2018
Immunosuppression Is Associated With Clinical Features and Relapse Risk of B Cell Posttransplant Lymphoproliferative Disorder: A Retrospective Analysis Based on the Prospective, International, Multicenter PTLD-1 Trials
Heiner Zimmermann, Nina Babel, Daan Dierickx, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 125) with videos related to
Sort By:
Page
of 13
Blood Advances
|
April 12, 2021
The landscape of copy number variations in classical Hodgkin lymphoma: a joint KU Leuven and LYSA study on cell-free DNA
Lieselot Buedts, Iwona Wlodarska, Julio Finalet-Ferreiro, et al.
British Journal of Haematology
|
December 14, 2020
Convalescent plasma treatment of persistent severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with lymphoma with impaired humoral immunity and lack of neutralising antibodies
Albrecht Betrains, Laurent Godinas, F J Sherida H Woei-A-Jin, et al.
Acta Neurologica Belgica
|
March 15, 2018
A Belgian consensus protocol for autologous hematopoietic stem cell transplantation in multiple sclerosis
Guy Laureys, Barbara Willekens, Ludo Vanopdenbosch, et al.
The Lancet. Oncology
|
February 3, 2024
Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial
Kris Michael Mahadeo, Robert Baiocchi, Amer Beitinjaneh, et al.
Thrombosis and Haemostasis
|
September 21, 2018
Anti-ADAMTS13 Autoantibodies against Cryptic Epitopes in Immune-Mediated Thrombotic Thrombocytopenic Purpura
Elien Roose, Gestur Vidarsson, Kadri Kangro, et al.
Journal of Crohn'S & Colitis
|
May 23, 2018
Autologous Haematopoietic Stem Cell Transplantation for Crohn's Disease: A Retrospective Survey of Long-term Outcomes From the European Society for Blood and Marrow Transplantation
Charlotte K Brierley, Cristina Castilla-Llorente, Myriam Labopin, et al.
The Lancet. Haematology
|
October 1, 2019
Obstetric and maternal outcomes in patients diagnosed with Hodgkin lymphoma during pregnancy: a multicentre, retrospective, cohort study
Charlotte Maggen, Daan Dierickx, Pieternella Lugtenburg, et al.
Eclinicalmedicine
|
May 26, 2021
Comprehensive genome-wide analysis of routine non-invasive test data allows cancer prediction: A single-center retrospective analysis of over 85,000 pregnancies
Liesbeth Lenaerts, Nathalie Brison, Charlotte Maggen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 20, 2016
Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial
Ralf U Trappe, Daan Dierickx, Heiner Zimmermann, et al.
Transplantation
|
May 15, 2018
Immunosuppression Is Associated With Clinical Features and Relapse Risk of B Cell Posttransplant Lymphoproliferative Disorder: A Retrospective Analysis Based on the Prospective, International, Multicenter PTLD-1 Trials
Heiner Zimmermann, Nina Babel, Daan Dierickx, et al.
Page
of 13